TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital

Chronological Source Flow
Back

AI Fusion Summary

Lake Street Capital cut its price target for TELA Bio (NASDAQ:TELA) from $3.00 to $2.00, maintaining a buy rating amid mixed brokerages. The move reflects a more cautious outlook on the biotech’s near‑term valuation.
26/03 09:41 defenseworld.net
3 Πηγές
26/03 10:39 defenseworld.net
26/03 12:05 yahoo.com
Comments
Loading...
0